Bronchiolitis obliterans following lung transplantation.
about
Apoptosis and the airway epitheliumBronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era.De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection.Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cellsLipid raft facilitated ligation of K-alpha1-tubulin by specific antibodies on epithelial cells: Role in pathogenesis of chronic rejection following human lung transplantation.Expression of calcineurin activity after lung transplantation: a 2-year follow-upAlloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.Bronchial wall measurements in patients after lung transplantation: evaluation of the diagnostic value for the diagnosis of bronchiolitis obliterans syndrome.The Induction of IgM and IgG Antibodies against HLA or MICA after Lung Transplantation.Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliteransAdherence to the medical regimen during the first two years after lung transplantationAltered Exosomal RNA Profiles in Bronchoalveolar Lavage from Lung Transplants with Acute RejectionUnderstanding chronic GVHD from different anglesLong term complications following 54 consecutive lung transplantsSolid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children.Differentiated transplant derived airway epithelial cell cytokine secretion is not regulated by cyclosporine.Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation.Double lung, unlike single lung transplantation might provide a protective effect on mortality and bronchiolitis obliterans syndrome.Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction.Cytotoxicity of Natural Killer Cells Activated Through NKG2D Contributes to the Development of Bronchiolitis Obliterans in a Murine Heterotopic Tracheal Transplant Model.Circulating Exosomes with Distinct Properties during Chronic Lung Allograft Rejection.
P2860
Q28741414-454E7912-DE64-4533-AE63-2EA92EE353A0Q30431852-59C10D09-8ACA-44DA-B510-6BF22BDACEE4Q33551885-22A98667-1F22-4B98-A7D5-549EBFBD5E14Q33627550-BC316481-1F1A-4374-AB54-79FD874AB831Q34079646-BA5AD7B6-3AFB-4BD1-AC36-415D8A5CA328Q34639769-9E13F4F3-9247-4CD9-A85B-CF02181ABE6FQ34970022-2CBA22FF-6320-450F-9E35-05AE5F359630Q35142720-05A3439F-5E21-4419-8AED-7BD1301077A1Q35195122-6BBEE541-469A-4DE3-B571-864E37BB062FQ35776453-5E3120E4-3ECE-48AD-BC19-D8B993667F05Q36070880-A240D60B-944A-4C5D-8539-9B4FC87769FBQ36516881-FFD526E2-3384-478C-A30B-B4E8F502D06AQ36551588-9CEE98C7-BE28-4CC8-A9FF-44F25E57751CQ36948920-9C402B11-5122-4BA0-8153-03EB845ED68BQ38129306-1F0CDC0D-6CC2-4BE8-BB89-F0069C248E39Q42116645-FE95572F-441D-4D51-8A3F-A85B672B8E8CQ42657222-61FE8516-EB76-49FA-99EF-3F431CF2E9B8Q47153176-AB933A75-D7EB-4A98-9E98-2869141EDECDQ48277199-42C04E1D-837D-431A-9FCE-3B0F5C0BC9DCQ51838387-09018E1A-FB2E-40CF-85AD-77EF4DC352ACQ52729829-0B198A23-6931-4A85-8B95-4147C5CFBFAA
P2860
Bronchiolitis obliterans following lung transplantation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Bronchiolitis obliterans following lung transplantation.
@ast
Bronchiolitis obliterans following lung transplantation.
@en
type
label
Bronchiolitis obliterans following lung transplantation.
@ast
Bronchiolitis obliterans following lung transplantation.
@en
prefLabel
Bronchiolitis obliterans following lung transplantation.
@ast
Bronchiolitis obliterans following lung transplantation.
@en
P2093
P2860
P1476
Bronchiolitis obliterans following lung transplantation.
@en
P2093
Anthony Yim
Gue-Wei He
Iskander Al-Githmi
Michael Hsin
Nadia Batawil
Norihisa Shigemura
Tak Wai Lee
P2860
P304
P356
10.1016/J.EJCTS.2006.09.027
P577
2006-10-19T00:00:00Z